39746-15-1Relevant articles and documents
METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH
-
Paragraph 0716-0717, (2015/02/02)
The present invention relates to novel bone compositions for locally delivering a therapeutic agent to the site of a bone defect. Therapeutic agents may promote repair of the bone defect and/or treat conditions or disorders such as pain, inflammation, cancer, and infection. The compositions include calcium phosphate cements and a demineralized bone matrix or a collagen sponge. The compositions are useful for implantation in a patient at the site of a bone defect.
GAMMA LACTAMS AS PROSTAGLANDIN AGONISTS AND USE THEREOF
-
Page 42, (2010/02/05)
1,2-substituted 5-pyrrolidinone compounds are provided, and methods of treatment and pharmaceutical composition that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, renal dysfunction, an immune deficiency disorder, dry eye, ichthyosis, elevated intraocular pressure, sleep disorder, or gastric ulcer, inflammatory disorders and other diseases and disorders associated with the prostaglandin family of compounds.
Copper(II) Bromide Utilization in the Synthesis of 15-Keto-PGB1 and its 16,16-Dimethyl Analog
Martin, I.,Anvelt, J.,Valimae, T.,Pehk, T.,Lille, O.
, p. 2597 - 2605 (2007/10/02)
Title compounds, monomeric intermediates of biologically active prostaglandin oligomers were synthesized using cupric bromide for introduction of a double bond into the prostanoid cyclopentane ring.
